116 related articles for article (PubMed ID: 34245207)
1. Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B-ALK fusion.
Sugiyama M; Hirabayashi S; Ishi Y; Kikuchi J; Ishikura A; Motegi H; Ueda Y; Sawai S; Hara K; Terashita Y; Cho Y; Takakuwa E; Honda S; Yamaguchi S; Kinoshita I; Manabe A
Pediatr Blood Cancer; 2021 Nov; 68(11):e29227. PubMed ID: 34245207
[No Abstract] [Full Text] [Related]
2. ALK-positive histiocytosis with
Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
[No Abstract] [Full Text] [Related]
3. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
Wolter NE; Ngan B; Whitlock JA; Dickson BC; Propst EJ
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109585. PubMed ID: 31351348
[TBL] [Abstract][Full Text] [Related]
4. Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel
Shimizu N; Akashi Y; Fujii T; Shiono H; Yane K; Kitahara T; Ohta Y; Kakudo K; Wakasa T
Anticancer Res; 2019 Jan; 39(1):413-420. PubMed ID: 30591488
[TBL] [Abstract][Full Text] [Related]
5. Disseminated ALK-positive histiocytosis with
Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
[No Abstract] [Full Text] [Related]
6. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour.
Maruggi M; Malicki DM; Levy ML; Crawford JR
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344149
[No Abstract] [Full Text] [Related]
7. TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma.
Mao W; Chen R; Zhang J; Zheng M
J Thorac Oncol; 2020 Mar; 15(3):e37-e39. PubMed ID: 32093858
[No Abstract] [Full Text] [Related]
8. A rare KIF5B-ALK fusion variant in a lung adenocarcinoma patient who responded to crizotinib and acquired the ALK L1196M mutation after resistance: a case report.
Zeng H; Liu Y; Wang W; Tang Y; Tian P; Li W
Ann Palliat Med; 2021 Jul; 10(7):8352-8357. PubMed ID: 33832282
[TBL] [Abstract][Full Text] [Related]
9. PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma.
Yang L; Zhao W; Zhu H; Li X; Zhao G
Lung Cancer; 2021 Apr; 154():219-220. PubMed ID: 33676770
[No Abstract] [Full Text] [Related]
10. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.
Feng T; Chen Z; Gu J; Wang Y; Zhang J; Min L
Lung Cancer; 2019 Nov; 137():19-22. PubMed ID: 31521978
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Characterization of Recurrent, Targetable ALK Fusions in Leiomyosarcoma.
Davis LE; Nusser KD; Przybyl J; Pittsenbarger J; Hofmann NE; Varma S; Vennam S; Debiec-Rychter M; van de Rijn M; Davare MA
Mol Cancer Res; 2019 Mar; 17(3):676-685. PubMed ID: 30518629
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.
Reinhart S; Trachsel Y; Fritz C; Wagner U; Bode-Lesniewska B; John H; Pless M
Urology; 2020 Dec; 146():32-35. PubMed ID: 33007314
[TBL] [Abstract][Full Text] [Related]
13. SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing.
Hou X; Xu H; Chen L
J Thorac Oncol; 2019 Apr; 14(4):e72-e73. PubMed ID: 30922581
[No Abstract] [Full Text] [Related]
14. Arsenic trioxide inhibits anaplastic lymphoma kinase (ALK)-positive diffuse large B-cell lymphoma through targeting ALK-fusion oncoprotein.
Yue LM; Chau D; Kwong YL; Tse E
Br J Haematol; 2021 Sep; 194(6):1085-1090. PubMed ID: 34121173
[No Abstract] [Full Text] [Related]
15. ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Kimura H; Nakajima T; Takeuchi K; Soda M; Mano H; Iizasa T; Matsui Y; Yoshino M; Shingyoji M; Itakura M; Itami M; Ikebe D; Yokoi S; Kageyama H; Ohira M; Nakagawara A
Lung Cancer; 2012 Jan; 75(1):66-72. PubMed ID: 21757253
[TBL] [Abstract][Full Text] [Related]
16. Subependymal giant cell astrocytoma harboring a PRRC2B-ALK fusion: A case report.
Tsurubuchi T; Nakano Y; Hirato J; Yoshida A; Muroi A; Sakamoto N; Alexander Z; Matsuda M; Ishikawa E; Kohno T; Yoshioka T; Honda-Kitahara M; Ichimura K; Yamamoto T; Matsumura A
Pediatr Blood Cancer; 2019 Dec; 66(12):e27995. PubMed ID: 31502411
[No Abstract] [Full Text] [Related]
17. Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib.
Luo J; Gu D; Lu H; Liu S; Kong J
J Thorac Oncol; 2019 Dec; 14(12):e266-e268. PubMed ID: 31757376
[No Abstract] [Full Text] [Related]
18. Concordance Analysis of ALK Gene Fusion Detection Methods in Patients with Non-Small-Cell Lung Cancer from Chile, Brazil, and Peru.
Sepúlveda-Hermosilla G; Freire M; Blanco A; Cáceres J; Lizana R; Ramos L; Assar Cuevas R; Ampuero D; Aren O; Chernilo S; Spencer ML; Bernal G; Flores J; Rasse G; Sánchez C; Marcelain K; Rivas S; Branco GP; Galli de Amorim M; Nunes DN; Dias-Neto E; Freitas HC; Fernández C; ; Pérez P; Armisén R
J Mol Diagn; 2021 Sep; 23(9):1127-1137. PubMed ID: 34186175
[TBL] [Abstract][Full Text] [Related]
19. MPRIP-ALK, a Novel ALK Rearrangement That Responds to ALK Inhibition in NSCLC.
Fang W; Gan J; Hong S; Lu F; Zhang L
J Thorac Oncol; 2019 Jul; 14(7):e148-e151. PubMed ID: 31235041
[No Abstract] [Full Text] [Related]
20. Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma.
Ise M; Kageyama H; Araki A; Itami M
Leuk Lymphoma; 2019 Feb; 60(2):493-497. PubMed ID: 30187817
[No Abstract] [Full Text] [Related]
[Next] [New Search]